Even the new CEO said "we aren't there yet". Stock is def going to 2 bucks.
product has years before it will gain traction. By then we will see a better diabetes drug on the market. I bought PUMA about a year ago and have been pleasantly surprised by the pps rise.
Al Mann no longer has anything to do with this company. He left the BoD a while back and is now trying to distance himself from what might become his first failed product rollout.
would love it, I"d buy some shares. Right now way too expensive for me.